85R8399 BK-D
 
  By: Sheffield H.R. No. 177
 
 
 
R E S O L U T I O N
         WHEREAS, Bleeding disorders, including hemophilia and von
  Willebrand disease, are genetic disorders that prevent the blood of
  sufferers from clotting properly, leading to debilitating and
  potentially fatal bleeding episodes; and
         WHEREAS, About 20,000 people in the United States are
  estimated to be affected with hemophilia, which results from a
  missing or deficient protein needed for blood clotting; an X-linked
  recessive trait, hemophilia is primarily found in males; and
         WHEREAS, The most common bleeding disorder, von Willebrand
  disease, also results from a defective blood protein but is
  typically milder than hemophilia; it is believed to affect up to one
  percent of the U.S. population, and many individuals, particularly
  women, go undiagnosed; and
         WHEREAS, Bleeding disorders can vary greatly in severity,
  with the most serious cases of hemophilia carrying the risk of
  excessive bleeding from accidents and surgeries, in addition to
  long-term damage to organs, tissues, and joints from internal
  bleeding over time; in recent decades, new medical developments and
  donor screening measures have greatly improved the safety and
  effectiveness of treatments such as factor replacement therapy,
  which can help patients to live normal, healthy lives; and
         WHEREAS, In 2016, the National Hemophilia Foundation
  declared March as Bleeding Disorders Awareness Month; this
  initiative is supported by Texas-based groups such as the Texas
  Bleeding Disorders Coalition, which is encouraging residents to
  participate in the Red Tie Challenge to help start a conversation
  about inheritable bleeding disorders and to promote advocacy for
  people who are living with bleeding disorders all over the world;
  and
         WHEREAS, While science and medicine have advanced greatly in
  the treatment of bleeding disorders, increased public awareness is
  needed to help ease the heavy financial burden and improve the
  quality of life of patients, and Bleeding Disorders Awareness Month
  provides an opportune time to join together in support of these
  worthy goals; now, therefore, be it
         RESOLVED, That the House of Representatives of the 85th Texas
  Legislature hereby recognize March 2017 as Bleeding Disorders
  Awareness Month and urge all Texans to learn more about these
  conditions.